Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net loss	$ (89,191)	$ (11,441)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation, amortization and accretion	25,277	16,620
Net loss on disposal of property and equipment	4,618	639
Share-based compensation	17,441	5,293
Interest expense, related party		1,926
Change in fair value of earnout liability	(1,328)	(3,695)
Change in fair value of warrant liability	(14,981)	(45,946)
Other	521	454
Changes in operating assets and liabilities
Accounts receivable, net	(3,987)	(3,505)
Receivables from related parties	1,500	(71)
Prepaid expenses and other current and noncurrent assets	840	(5,188)
Operating lease assets and liabilities, net	(1,082)
Accounts payable	(45)	(204)
Payables to related parties	24	458
Accrued liabilities	1,567	2,321
Deferred revenue	3,544	20,943
Customer deposits	(1,795)	4,641
Other current and noncurrent liabilities	(260)	(1,042)
Net cash used in operating activities	(57,337)	(17,797)
Cash flows from investing activities
Purchases of property, equipment and software	(133,885)	(39,679)
Proceeds from insurance for property losses	729
Purchases of investments	(37,332)
Proceeds from sale of investments	37,166
Acquisition of business, net of cash received		(22,762)
Net cash used in investing activities	(133,322)	(62,441)
Cash flows from financing activities
Proceeds from CRIS Business Combination		601,579
Proceeds from note payable, related party		24,000
Payments on note payable, related party		(5,500)
Proceeds from exercise of warrants	3
Capital-build funding, net	6,864	1,516
Payment of transaction costs for CRIS Business Combination		(28,143)
Payment of deferred transaction costs	(409)
Net cash provided by financing activities	6,458	593,452
Net (decrease) increase in cash and restricted cash	(184,201)	513,214
Cash and restricted cash, beginning of period	485,181	7,914
Cash and restricted cash, beginning of period	300,980	521,128
Supplemental disclosure of noncash investing and financing activities
Accrued transaction costs	152	300
Asset retirement obligations incurred	2,841	1,671
Non-cash increase in accounts receivable, capital-build and capital-build liability	6,199	4,228
Purchases of property and equipment in accounts payable and accrued liabilities	32,939	10,848
Reclassification of contingent earnout liability to equity upon triggering event		10,853
Contingent earnout liability recognized upon closing of CRIS Business Combination		18,278
Conversion of note payable, related party, to equity		59,590
Reclassification of redeemable noncontrolling interest on CRIS Close Date		436,739
Fair value adjustment to redeemable noncontrolling interest	$ 332,831	$ 1,141,037